Carmen Streibel
Overview
Explore the profile of Carmen Streibel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kieninger E, Munidasa S, Curdy M, Streibel C, Zanette B, Woods J, et al.
J Cyst Fibros
. 2025 Mar;
PMID: 40069051
Introduction: Functional magnetic resonance imaging (MRI) of the lung usually assesses lung impairment as ventilation defect percentage (VDP). However, VDP only reflects the overall burden of disease and does not...
2.
Buckert M, Streibel C, Hartmann M, Monzer N, Kopf S, Szendrodi J, et al.
Front Public Health
. 2024 May;
12:1289689.
PMID: 38813430
Introduction: Increasing evidence supports chronic psychological stress as a risk factor for the development of type 2 diabetes. Much less is known, however, about the role of chronic stress in...
3.
Streibel C, Willers C, Bauman G, Pusterla O, Bieri O, Curdy M, et al.
Eur Radiol
. 2023 Nov;
34(6):3773-3785.
PMID: 37982833
Objectives: In patients with congenital diaphragmatic hernia (CDH) the exact functional outcome of the affected lung side is still unknown, mainly due to the lack of spatially resolved diagnostic tools....
4.
Ardura-Garcia C, Kainz K, Mallet M, Petrarca L, Rodman Berlot J, Slaats M, et al.
ERJ Open Res
. 2023 May;
9(3).
PMID: 37228264
This review has been prepared by the Early Career Members and Chairs of the European Respiratory Society (ERS) Assembly 7: Paediatrics. We here summarise the highlights of the advances in...
5.
Streibel C, Willers C, Pusterla O, Bauman G, Stranzinger E, Brabandt B, et al.
J Cyst Fibros
. 2023 Jan;
22(4):615-622.
PMID: 36635199
Background: With improvement in supportive therapies and the introduction of cystic fibrosis transmembrane conductance regulator (CFTR)-modulator treatment in patients with cystic fibrosis (CF), milder disease courses are expected. Therefore, sensitive...